Ross John | Department Of Medicine University Of California
スポンサーリンク
概要
関連著者
-
Iwanaga Yoshitaka
Department Of Cardiology National Cardiovascular Center
-
Ross John
Department of Medicine, University of California
-
Ross John
Department Of Medicine University Of California
-
Ross John
Department Of Chemistry Massachusetts Institute Of Technology
-
Ikeda Yasuhiro
Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate S
-
Matsuzaki Masunori
Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate S
-
Minamisawa Susumu
Department Of Life Science And Medical Bio-science Waseda University Graduate School Of Advanced Sci
-
Minamisawa Susumu
Department Of Life Science And Medical Bio-science Waseda University Advanced Science And Engineerin
-
Kenneth Chien
Department Of Medicine University Of California
-
Minamisawa Susumu
Department Of Pediatric Cardiology Tokyo Women's Medical Colledge
-
Iwanaga Yoshitaka
Department Of Medicine Unversity Of California
-
Ikeda Yasuhiro
Department Of Dental Science Institute Of Personalized Medical Science Health Sciences University Of
-
Iwanaga Yoshitaka
Department Of Medicine University Of California
-
Hoshijima Masahiko
Department of Medicine, University of California
-
Matsuzaki Masunori
Department Of Cardiology Kyushu Kousei-nenkin Hospital
-
Condorelli Gianluigi
II Faculty of Medicine, University "La Sapienza"
-
Matsuzaki Masunori
Department Of Cardiovascular Medicine Yamaguchi University
-
Condorelli Gianluigi
Ii Faculty Of Medicine University "la Sapienza
-
Ross John
Department Of Medicine Unversity Of California
-
Hoshijima Masahiko
Department Of Medicine Center For Research In Biological Systems University Of California San Diego
-
Ikeda Yasuhiro
Department Of Cardiovascular Medicine Yamaguchi University
-
Ikeda Yasuhiro
Department of Cardiology, Yamaguchi Grand Medical Center
著作論文
- Chronic Heart Failure Therapy via Cardiotropic rAAV Delivery of an S16E Mutant Phospholamban
- A Nitric Oxide-Releasing Derivative of Enalapril, NCX-899, Prevents Progressive LV Dysfunction and Improves Remodeling in Cardiomyopathic Hamsters with Heart Failure